April 12, 1995 |
The first U.S. trial of a Russian technique for transplanting fetal pancreatic cells into diabetics has led to increased insulin production and a marked improvement in the control of blood sugar levels among the 24 patients who received the grafts, according to Santa Barbara scientists. Virtually all of the recipients received some benefit from the transplants, a marked improvement over previous U.S. trials in which few transplant recipients showed improvements.
April 26, 1993 |
Fetal cell transplants and electronic sensors may eventually help restore partial vision in people whose light-sensitive retinal cells have been destroyed by diseases such as diabetic retinopathy, researchers said in Los Angeles on Sunday. In such diseases, which affect at least 1.8 million Americans, nerve pathways from the eye to the brain are functional. Only the eye's ability to detect light is impaired.
CALIFORNIA | LOCAL
January 15, 1990 |
The timing was ironic. As 12,000 researchers gathered recently at the Society for Neuroscience's annual meeting, Health and Human Services Secretary Louis W. Sullivan extended indefinitely a ban on federally funded fetal tissue transplants. The moratorium, which predominantly affects neuroscientists, forbids federal support for experimental transplants into humans of tissue from intentionally aborted fetuses.
March 14, 2005 |
Hundreds of diabetics can now live without daily injections after receiving transplants of insulin-producing cells. These cells, taken from the pancreases of several cadavers, quickly set to work inside their new hosts to produce the glucose-regulating hormone. But most diabetics aren't candidates for the transplants. There simply aren't enough organs available to provide the cells.
April 22, 2002 |
A new type of cell transplant to treat Parkinson's disease appears to significantly improve patients' movements while avoiding the ethical quandaries linked to fetal and stem cell use. The technique, which so far has been tested only in six patients, uses eye cells obtained from a cadaver donor.
September 17, 1992 |
Major advances in healing damaged spines, the most important cause of paralysis, were reported Wednesday by two independent research groups. One group used fetal cell transplants to restore near-normal function in the rear legs of cats that had suffered paralyzing spinal damage, apparently the first report of such success in any mammal.
CALIFORNIA | LOCAL
May 7, 1992 |
Two types of experimental surgical procedures have significantly improved the conditions of patients with Parkinson's disease, surgeons said here Wednesday. Two teams of researchers independently reported that in a total of 11 patients, grafts of fetal tissue obtained during abortions sharply reduced tremors and rigidity and increased control of limb functions.
September 9, 2002 |
Daily insulin injections are lifesaving for diabetics, but to many people they rep-resent a heavy burden that can interfere with their professional and social lives. The wide swings in blood sugar levels that can occur when injections are given only once or twice a day, furthermore, are now known to be the cause of virtually all the complications of diabetes, ranging from nerve damage to heart disease to blindness.
June 7, 2000 |
Canadian researchers have successfully freed eight diabetics from insulin dependence by using a new combination of anti-rejection drugs to transplant insulin-secreting islet cells. All of the subjects have remained insulin-free for four to 15 months, a remarkable rate, because fewer than one in 10 patients who received islet transplants previously were able to escape their daily shots. "This is perhaps the most important finding in Type 1 diabetes research in the past decade," said Dr.
April 16, 1988 |
When diabetic Rich Shultz received a transplant of pancreatic cells taken from an aborted human fetus two years ago, the Santa Barbara man became a participant in a fast-growing but controversial field of experimental therapy. Many biomedical researchers believe that fetal tissues and cells have enormous potential for helping hundreds of thousands of people with hormone-deficiency disorders such as Parkinson's, Huntington's and Alzheimer's diseases, as well as diabetes.